Carmen Behrens

发表

Data driven semantic integration of translational lung cancer research at MDAnderson Cancer Center.

Bradley Broom, Stephen G Swisher, Harold R Garner, 2008, AMIA ... Annual Symposium proceedings. AMIA Symposium.

Divergent Genomic and Epigenomic Landscapes of Lung Cancer Subtypes Underscore the Selection of Different Oncogenic Pathways during Tumor Development

John D. Minna, John Yee, Raj Chari, 2011, PloS one.

Genomic heterogeneity of multiple synchronous lung cancer

Dongmei Lin, Li Zhang, John V Heymach, 2016, Nature Communications.

Essential Role of Aldehyde Dehydrogenase 1A3 for the Maintenance of Non–Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway

John D. Minna, Jaime Rodriguez-Canales, Chunli Shao, 2014, Clinical Cancer Research.

Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches

Boris Sepesi, Ignacio I. Wistuba, John V. Heymach, 2018, Journal of Immunotherapy for Cancer.

The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network

Jiang Yu, Lixia Diao, Jing Wang, 2018, The Journal of clinical investigation.

Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features

Stephen G Swisher, B Nebiyou Bekele, Shyam Biswal, 2010, Clinical Cancer Research.

Sex Determining Region Y-Box 2 (SOX2) Is a Potential Cell-Lineage Gene Highly Expressed in the Pathogenesis of Squamous Cell Carcinomas of the Lung

John D. Minna, Humam Kadara, Yang Xie, 2010, PloS one.

Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

Clement Adebamowo, Ritika Kundra, Steven J. M. Jones, 2018, Cell reports.

Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer

John D. Minna, Guanghua Xiao, Yang Xie, 2010, PLoS medicine.

Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival.

Xudong Dai, Chenchen Yang, Muneesh Tewari, 2015, Cancer research.

Multiplatform-based Molecular Subtypes of Non-Small Cell Lung Cancer

Yiling Lu, Rehan Akbani, Gordon B. Mills, 2016, Oncogene.

An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer

Jaime Rodriguez-Canales, Yang Xie, Luc Girard, 2016, Clinical Cancer Research.

Prognostic Significance of RNA-Dependent Protein Kinase on Non–Small Cell Lung Cancer Patients

Stephen G Swisher, Koji Tsuta, Luisa Solis, 2010, Clinical Cancer Research.

Nuclear factor‐κB (nf‐κB) is frequently expressed in lung cancer and preneoplastic lesions

Bharat B. Aggarwal, Ignacio I. Wistuba, Shishir Shishodia, 2006 .

Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis

Humam Kadara, Diane D. Liu, Diane D Liu, 2011, Clinical Cancer Research.

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

Tao Wang, Yang Xie, Chunli Shao, 2014, Proceedings of the National Academy of Sciences.

Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer

Boris Sepesi, Joe Y. Chang, Laurence Court, 2018, Scientific Reports.

Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients

Jaime Rodriguez-Canales, Humam Kadara, Boris Sepesi, 2016, Clinical Cancer Research.

Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers

Michael Q. Zhang, Yang Xie, Xiaotu Ma, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.

Luc Girard, Suzie K. Hight, Dhruba Deb, 2016, The Journal of clinical investigation.

TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.

Ryan Emerson, Jaime Rodriguez-Canales, Boris Sepesi, 2017, Cancer discovery.

A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis

John D. Minna, Humam Kadara, Edward S. Kim, 2010, Clinical Cancer Research.

Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.

Michael Peyton, Humam Kadara, Murim Choi, 2015, Cancer discovery.

CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.

John V Heymach, Young-Ho Ahn, Roy S Herbst, 2013, Cancer research.

The Role of PKR/eIF2α Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer

Ignacio I. Wistuba, Liping Yu, Yihong Zhou, 2011, PloS one.

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy

Ara A Vaporciyan, Stephen G Swisher, J Jack Lee, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.

Boris Sepesi, Joe Y. Chang, Wen Yu, 2017, International journal of radiation oncology, biology, physics.

HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors

Carmen Behrens, Ignacio I Wistuba, K. Aldape, 2009, Clinical Cancer Research.